These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 9610731
1. Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide. Kundu N, Dorsey R, Jackson MJ, Guiterrez P, Wilson K, Fu S, Ramanujam K, Thomas E, Fulton AM. Int J Cancer; 1998 May 29; 76(5):713-9. PubMed ID: 9610731 [Abstract] [Full Text] [Related]
2. Essential role of nitric oxide and interferon-gamma for tumor immunotherapy with interleukin-10. Sun H, Gutierrez P, Jackson MJ, Kundu N, Fulton AM. J Immunother; 2000 May 29; 23(2):208-14. PubMed ID: 10746547 [Abstract] [Full Text] [Related]
3. Interleukin-10 gene transfer activates interferon-gamma and the interferon-gamma-inducible genes Gbp-1/Mag-1 and Mig-1 in mammary tumors. Sun H, Jackson MJ, Kundu N, Fulton AM. Int J Cancer; 1999 Feb 09; 80(4):624-9. PubMed ID: 9935167 [Abstract] [Full Text] [Related]
4. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. Xie K, Huang S, Dong Z, Juang SH, Gutman M, Xie QW, Nathan C, Fidler IJ. J Exp Med; 1995 Apr 01; 181(4):1333-43. PubMed ID: 7535333 [Abstract] [Full Text] [Related]
5. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Jadeski LC, Hum KO, Chakraborty C, Lala PK. Int J Cancer; 2000 Apr 01; 86(1):30-9. PubMed ID: 10728591 [Abstract] [Full Text] [Related]
6. Arginine-enhanced enteral nutrition augments the growth of a nitric oxide-producing tumor. Edwards PD, Topping D, Kontaridis MI, Moldawer LL, Copeland EM, Lind DS. JPEN J Parenter Enteral Nutr; 1997 Apr 01; 21(4):215-9. PubMed ID: 9252947 [Abstract] [Full Text] [Related]
7. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. Kundu N, Beaty TL, Jackson MJ, Fulton AM. J Natl Cancer Inst; 1996 Apr 17; 88(8):536-41. PubMed ID: 8606382 [Abstract] [Full Text] [Related]
8. Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Orucevic A, Bechberger J, Green AM, Shapiro RA, Billiar TR, Lala PK. Int J Cancer; 1999 Jun 11; 81(6):889-96. PubMed ID: 10362135 [Abstract] [Full Text] [Related]
9. Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies. Hajri A, Metzger E, Vallat F, Coffy S, Flatter E, Evrard S, Marescaux J, Aprahamian M. Br J Cancer; 1998 Oct 11; 78(7):841-9. PubMed ID: 9764573 [Abstract] [Full Text] [Related]
10. Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene. Xie K, Huang S, Dong Z, Juang SH, Wang Y, Fidler IJ. J Natl Cancer Inst; 1997 Mar 19; 89(6):421-7. PubMed ID: 9091643 [Abstract] [Full Text] [Related]
11. Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma. Dorsey R, Kundu N, Yang Q, Tannenbaum CS, Sun H, Hamilton TA, Fulton AM. Cancer Res; 2002 May 01; 62(9):2606-10. PubMed ID: 11980656 [Abstract] [Full Text] [Related]
12. Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Kolios G, Brown Z, Robson RL, Robertson DA, Westwick J. Br J Pharmacol; 1995 Dec 01; 116(7):2866-72. PubMed ID: 8680718 [Abstract] [Full Text] [Related]
13. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Thomsen LL, Scott JM, Topley P, Knowles RG, Keerie AJ, Frend AJ. Cancer Res; 1997 Aug 01; 57(15):3300-4. PubMed ID: 9242464 [Abstract] [Full Text] [Related]
14. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Xie K, Fidler IJ. Cancer Metastasis Rev; 1998 Mar 01; 17(1):55-75. PubMed ID: 9544423 [Abstract] [Full Text] [Related]
15. Transfection of K-rasAsp12 cDNA markedly elevates IL-1beta- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells. Takahashi M, Mutoh M, Shoji Y, Kamanaka Y, Naka M, Maruyama T, Sugimura T, Wakabayashi K. Oncogene; 2003 Oct 23; 22(48):7667-76. PubMed ID: 14576830 [Abstract] [Full Text] [Related]
16. Regulation by endogenous INTERLEUKIN-10 of the expression of nitric oxide synthase induced after ligation of CD23 in human macrophages. Dugas N, Palacios-Calender M, Dugas B, Riveros-Moreno V, Delfraissy JF, Kolb JP, Moncada S. Cytokine; 1998 Sep 23; 10(9):680-9. PubMed ID: 9770329 [Abstract] [Full Text] [Related]
17. Heparin-binding EGF-like growth factor down regulates proinflammatory cytokine-induced nitric oxide and inducible nitric oxide synthase production in intestinal epithelial cells. Lara-Marquez ML, Mehta V, Michalsky MP, Fleming JB, Besner GE. Nitric Oxide; 2002 Mar 23; 6(2):142-52. PubMed ID: 11890738 [Abstract] [Full Text] [Related]
18. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. Wang B, Xiong Q, Shi Q, Le X, Abbruzzese JL, Xie K. Cancer Res; 2001 Jan 01; 61(1):71-5. PubMed ID: 11196200 [Abstract] [Full Text] [Related]
19. Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection. Di Carlo E, Coletti A, Modesti A, Giovarelli M, Forni G, Musiani P. Eur Cytokine Netw; 1998 Mar 01; 9(1):61-8. PubMed ID: 9613679 [Abstract] [Full Text] [Related]
20. Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells. Kunz D, Walker G, Eberhardt W, Messmer UK, Huwiler A, Pfeilschifter J. J Clin Invest; 1997 Dec 01; 100(11):2800-9. PubMed ID: 9389745 [Abstract] [Full Text] [Related] Page: [Next] [New Search]